Scroll up to People

Latest News

Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
PRESS RELEASE NOVEMBER 15, 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
PRESS RELEASE NOVEMBER 03, 2022
Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome
PORTFOLIO NEWS OCTOBER 11, 2022
Sunny days for Nimbus: Lilly inks $496M biobucks deal for potential metabolic disease therapies
Published in Fierce Biotech
PORTFOLIO NEWS OCTOBER 06, 2022
Nuvalent Appoints Michael L. Meyers, MD, PhD, to Board of Directors
PORTFOLIO NEWS OCTOBER 05, 2022
Areteia Therapeutics announces the appointments of Dr. Eric Bradford as Chief Medical Officer, and Robin Walker as Chief Legal Officer and Corporate Secretary
PORTFOLIO NEWS SEPTEMBER 30, 2022
Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement
PORTFOLIO NEWS SEPTEMBER 29, 2022
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS
PORTFOLIO NEWS SEPTEMBER 22, 2022
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment of Obesity and Cardio-Metabolic Disorders
PORTFOLIO NEWS SEPTEMBER 22, 2022
Areteia Therapeutics named as one of the Most Promising Biotech Startups of 2022
See all Life Sciences news >
Scroll down to Contact
_
_